Progress towards precision medicine for lupus: the role of genetic biomarkers
- 12 February 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Precision Medicine and Drug Development
- Vol. 3 (2) , 119-135
Abstract
Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease (AD). Precision medicine gives clinicians and society access to the information needed to create individually tailored programs to predict, prevent, and treat SLE. Although several biomarkers have been described for SLE, current expansion of knowledge on lupus genetics makes the implementation of genetic biomarkers possible. Herein, a comprehensive description of relevant SLE genetic biomarkers from the precision medicine perspective is offered. National inception cohorts should be created and the implementation of translational programs for the control of ADs such as SLE should be put into practice. Factors that are predictive of developing these conditions should be examined at the population level in order to establish preventive measures in at-risk individuals for whom healthcare should be personalized/precise and participatory. The implementation of such a program will allow the discovery of new mechanisms and a new taxonomy of ADs. The translational model should also involve educational and training programs together with digital participatory surveillance systems. Healthcare’s one-size-fits-all approach to treating patients will be replaced with a personalized/precision approach to medicine that focuses on individuals and each family member.Keywords
Funding Information
- Departamento Administrativo de Ciencia, Tecnologia e Innovacion (ABN011)
- Universidad del Rosario (122254531722)
This publication has 196 references indexed in Scilit:
- Unraveling Multiple MHC Gene Associations with Systemic Lupus Erythematosus: Model Choice Indicates a Role for HLA Alleles and Non-HLA Genes in EuropeansThe American Journal of Human Genetics, 2012
- Contribution of STAT4 gene single-nucleotide polymorphism to systemic lupus erythematosus in the Polish populationMolecular Biology Reports, 2012
- Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association studyArthritis & Rheumatism, 2011
- Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosusArthritis & Rheumatism, 2010
- Confirmation of an association between rs6822844 at the Il2–Il21 region and multiple autoimmune diseases: Evidence of a general susceptibility locusArthritis & Rheumatism, 2010
- Evaluation of C1q genomic region in minority racial groups of lupusGenes & Immunity, 2009
- Fcγ receptors: structure, function and role as genetic risk factors in SLEGenes & Immunity, 2009
- Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysisGenes & Immunity, 2009
- Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestationsGenes & Immunity, 2009
- A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus ErythematosusImmunity, 2008